Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: Comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity

Journal of Comparative Neurology

Volumn 362, Issue 3, 1995, Pages 400-410

  Haber, S N ^a   Ryoo, H ^a   Cox, C ^a   Lu, W ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

dorsal tier; pars coinpacta; primate; ventral tier; VTA

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CALBINDIN; CARRIER PROTEIN; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE EXPRESSION; IMMUNOREACTIVITY; MESENCEPHALON; MONKEY; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; VENTRAL TEGMENTUM;

ANIMAL; ANTIBODY SPECIFICITY; BASE SEQUENCE; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CARRIER PROTEINS; COMPARATIVE STUDY; DOPAMINE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACACA NEMESTRINA; MESENCEPHALON; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEURONS; NISSL BODIES; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TYROSINE 3-MONOOXYGENASE;

EID: 0028838720     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.903620308     Document Type: Article

References (57)

1. Calcium‐binding proteins: Selective markers of nerve cells
2. Coexpression of dopamine transporter mRNA and tyrosine hydroxylaee mRNA in ventral mesencaphalic neurons
3. Calcium‐binding proteins in the nervous system
4. Efferent connections of the substantia nigra and ventral tegmental area in the rat
5. Cloning and expression of a rat D2 dopamine receptor cDNA
6. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compact of the substantia nigra by N‐niethyl‐4‐phtnyl‐1,2,3,6tetrahydropyridine
7. Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain
8. Mesostriatal and mesolimbic dopamine uptake binding sitei are reduced in parkinson's disease and progressive supranuclear palsy: A quantitative autoradiographic study using [3H] mazindol
9. Oxidative stress, glutamate, and neurodegenerative disorders
10. The afferent connections of the main and the accessory olfactory bulb formations in the rat: An experimental HRP‐study
11. Catecholamine innervation of the basal forebrain IV. Topography of the dopamine projections to the basal forebrain and neostriatum
12. Catecholamine innervation of the basal forebrain
13. Nourotonsin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patients
14. A histological atlas of the macaqua (Macaca mulatta) subatantia nigra in ventricular coordinates
15. Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotranamission
16. The neostriatal mosaic: III Biochemical and developmental dissociation of patch‐matrix mesostriatal systems
17. Ihe neostriatal mosaic: II. Patch‐ and matrix‐directed mesostriatal dopaminergic and non‐dopaminergic systems
18. MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease
19. 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced parkinsonian syndrome in Macaca fascicularis: Which midbrain dopaminergic neurons are lost?
20. Alternative splicing directs the expression of two D2 dopamine receptor isoforms
21. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter
22. Cloning of the cDNA and gene for a human D2 dopamine receptor
23. Dopamine transporter sites selectively labeled by a novel photoaffinity probe
24. A single human gene encoding multiple tyrosine hydroxylase with different predicted functional characteristics
25. Comparative anatomy of the ventromedial mesencephalic tegmentum in the rat, cat, monkey and human
26. Enzymatic oxidation of dopamine: The role of prostaglandin H synthase
27. 3H]dopamine: Impact of ascorbic acid and glutathione
28. Parkinsonism‐inducing neurotoxin, N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine: Uptake of the metabolito N‐methyl‐4‐phenylpyridine by dopamine neurons explains selective toxicity
29. Dopamina transporter: Biochemistry, pharmacology and imaging
30. Selective nigral toxicity after systemic administration of 1‐methyl‐4‐phenyl‐1,2,5,6‐tetrahydropyridine (MPTP) in the squirrel monkey
31. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys
32. In situ hybridization histochemistry: A new method for processing material stored for several years
33. The organization of midbrain projections to the ventral striatum in the primate
34. The organization of midbrain projections to the striatum in the primate: Sensorimotor‐related striatum versus ventral striatum
35. Expression of the dopsrnine D2 receptor gene in brain
36. Distribution of D2 dopamirie receptor mRNA in the primate brain
37. Differential expression of autoreceptors in the ascending dopamine systems of the human brain
38. Localization of the mRNA for the dopamine D2 receptor in the rat brain by in situ hybridization histochemistry
39. Visualization of dopamine D1 receptor mRNA in human and rat brain
40. Sites of the neurotoxic action of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus
41. Multiple D2 dopamine receptors produced by alternative RNA splicing
42. Efferent connections and nigral afferents of the nucleus accumbens septi in the rat
43. The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus
44. The topographic order of inputs to nucleus accumbens in the rat
45. Dopamine transporter expression confers cytotoxicity to low doses of the Parkinsoniam‐inducing neuro toxin 1‐methyl‐4‐phenylpyridinium
46. Effect of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey
47. Comparative morphology of the substantia nigra and ventral tegmental area in the monkey, cat and rat
48. Chronic exposure to low doses of MPTP. II. Neurochemical and pathological consequences in cognitively‐impaired, motor asymptomatic monkeys
49. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP
50. Ultrastructural localization of D2 receptor‐like immunoreactivity in midbrain dopamine neurons and their striatal targets
51. Dopamine transporter mRNA: Dense expression in ventral midbrain neurons
52. 2 chelators reduce earh excitotoxic and ischemic neuronal injury in vitro and in vivo
53. A cloned dopamine transporter: Potential insights into Parkinson's disease pathogenesis
54. Use of cryoprotectant to maintain long‐term peptide immunoreactivity and tissue morphology
55. D1 and D2 dopamine receptor mRNA in rat brain
56. Dl and D2 dopamine receptor mRNA in rat brain